Clinical investigations revealed significant downregulation of miR-16-5p and a concurrent rise of lncRNA-TCF7 and SEMA3A in serum samples from patients with DN, with these aberrant expression profiles demonstrating positive correlations with hyperglycemic indices (blood glucose and glycated hemoglobin) and uACR (86). This evidence concerns the gene SEMA3A and liver dysplastic nodule.